Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jul;19(7):102563.
doi: 10.1016/j.autrev.2020.102563. Epub 2020 May 5.

Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection

Louise Cunningham  1 , Ian Kimber  2 , David Arthur Basketter  3 , John Paul McFadden  4
Affiliations
Comment

Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection

Louise Cunningham et al. Autoimmun Rev. 2020 Jul.
No abstract available

Keywords: COVID-19; Cytokine storm; IL-6; Interleukin-6; Macrophage activation syndrome; Natural killer cells; Perforin; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest There are no conflicts of interest for any of the authors.

Comment in

Comment on

References

    1. McGonagle D., Sharif K., O’Regan A., Bridgewood C. The role of cytokines including Interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;102537 - PMC - PubMed
    1. Schulert G.S., Yasin S., Carey B., Chalk C., Do T., Schapiro A.H. Systemic juvenile idiopathic arthritis-associated lung disease: characterization and risk factors. Arthritis Rheumatol (Hoboken, NJ) 2019;71(11):1943–1954. - PMC - PubMed
    1. Velazquez-Salinas L., Verdugo-Rodriguez A., Rodriguez L.L., Borca M.V. The role of interleukin 6 during viral infections. Front Microbiol. 2019;10:1057. - PMC - PubMed
    1. Voskoboinik I., Whisstock J.C., Trapani J.A. Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol. 2015;15(6):388–400. - PubMed
    1. Cifaldi L., Prencipe G., Caiello I., Bracaglia C., Locatelli F., De Benedetti F. Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome. Arthritis Rheumatol (Hoboken, NJ) 2015;67(11):3037–3046. - PubMed